# Feasibility, Efficacy and Safety of IBS ® for Implantaiton in the PDA in Duct-dependent Cyanotic CHD

> **NCT04291222** · NA · UNKNOWN · sponsor: **Lifetech Scientific (Shenzhen) Co., Ltd.** · enrollment: 10 (estimated)

## Conditions studied

- Patent Ductus Arteriosus
- Duct-dependent Cyanotic Congenital Heart Disease

## Interventions

- **DEVICE:** Iron biocorrodable coronary scaffold system

## Key facts

- **NCT ID:** NCT04291222
- **Lead sponsor:** Lifetech Scientific (Shenzhen) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-11
- **Primary completion:** 2020-08
- **Final completion:** 2021-08
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2020-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04291222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04291222, "Feasibility, Efficacy and Safety of IBS ® for Implantaiton in the PDA in Duct-dependent Cyanotic CHD". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04291222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*